Impatient shareholders and likely aggressive short sellers sold enough shares over the last two sessions to drive Ampio's share price down creating even more angst for loyal Ampio shareholders but it is also creating buying opportunity because shares were EXTREMELY undervalued at $5 and now they are even cheaper.
Grab them while you can because they won't stay at these cheap levels for long. Ampio's story is too good and there is NO OTHER COMPANY out there with this kind of potentially SUPER EXPLOSIVE GROWTH.
Note that the company revised the language in its presentation they will be giving at UBS tomorrow from "ACTIVELY SEEKING PARTNER" to "LATE STAGE DISCUSSIONS".
Anything is possible but the one thing that has not changed is that Ampio is holding all the cards and owns 100% of Zertane AND ZERTANE ED that will very likely become huge blockbusters. Just imagine ZERTANE ED, a pill for both PE ad ED and realize that Pfizer's Viagra is coming off patent very soon. $$$$$$$$$
Ampio may not be very good at optimizing shareholder values but they are sheer genius at developing incredibly valuable drugs in record time at record low cost and with record low risk.
Apart from huge potential the other thing I like about the management is that they are very conscious about dilution unlike other startup pharmas ... which shows alot of confidence in their product and ability to execute.. most of them keep diluting till the SP hits pennies